Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...
XPeng Inc. surged after unveiling IRON, humanoid robot, outpacing Tesla, Inc.'s progress in robotics. Learn more about XPEV ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果